Zydus announces phase-IV Dream-CKD trial to generate real-world evidence of Desidustat in patients… EP News Bureau Aug 31, 2022 Oxemia (Desidustat) is a prescription drug approved in India for patients with Chronic Kidney Disease (CKD)-induced anaemia, and…
